Dexmedetomidine Pharmacology in Neonates and Infants after Open Heart Surgery

Anesthesia and Analgesia

Volumn 122, Issue 5, 2016, Pages 1556-1566

  Su, Felice ^a   Gastonguay, Marc R ^b   Nicolson, Susan C ^a   Diliberto, Maryann ^a   Ocampo Pelland, Alanna ^c   Zuppa, Athena F ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Metrum Institute   (United States)

^c University of Connecticut   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; HYPNOTIC SEDATIVE AGENT;

ARTICLE; ARTIFICIAL VENTILATION; ATRIAL ECTOPY; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BODY WEIGHT; CARDIOPULMONARY ARREST; CARDIOPULMONARY BYPASS; CARDIOPULMONARY INSUFFICIENCY; COHORT ANALYSIS; COMPLETE HEART BLOCK; CONGENITAL HEART DISEASE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG WITHDRAWAL; ECTOPIA CORDIS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART SEPTUM DEFECT; HEART TAMPONADE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTENSION; INFANT; INTRAVENOUS CATHETER; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OPEN HEART SURGERY; PERIPHERAL VOLUME OF DISTRIBUTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ST SEGMENT; T WAVE INVERSION; TANDEM MASS SPECTROMETRY; AGE; BIOLOGICAL MODEL; BLOOD; CLINICAL TRIAL; COMPUTER SIMULATION; DOSE CALCULATION; DRUG ADMINISTRATION; DRUG MONITORING; HEART DEFECTS, CONGENITAL; HEART SURGERY; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; MONTE CARLO METHOD; NONLINEAR SYSTEM; PRESCHOOL CHILD; PROCEDURES; TERM BIRTH; TREATMENT OUTCOME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; AGE FACTORS; ANALGESICS, NON-NARCOTIC; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTER SIMULATION; DEXMEDETOMIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; HEART DEFECTS, CONGENITAL; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; NONLINEAR DYNAMICS; RESPIRATION, ARTIFICIAL; TANDEM MASS SPECTROMETRY; TERM BIRTH; TREATMENT OUTCOME;

EID: 84964430229     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000869     Document Type: Article

References (40)

1. Heinle JS, Diaz LK, Fox LS, Early extubation after cardiac operations in neonates and young infants. J Thorac Cardiovasc Surg 1997 114 413 8
2. Neirotti RA, Jones D, Hackbarth R, Paxson Fosse G, Early extubation in congenital heart surgery. Heart Lung Circ 2002 11 157 61
3. Yamasaki Y, Shime N, Miyazaki T, Yamagishi M, Hashimoto S, Tanaka Y, Fast-track postoperative care for neonatal cardiac surgery: a single-institute experience. J Anesth 2011 25 321 9
4. Baddigam K, Russo P, Russo J, Tobias JD, Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005 20 118 23
5. Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R, Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg 2008 107 1514 22
6. Finkel JC, Johnson YJ, Quezado ZM, The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005 33 2110 2
7. Mester R, Easley RB, Brady KM, Chilson K, Tobias JD, Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization. Am J Ther 2008 15 24 30
8. Mukhtar AM, Obayah EM, Hassona AM, The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg 2006 103 52 6
9. Munro HM, Tirotta CF, Felix DE, Lagueruela RG, Madril DR, Zahn EM, Nykanen DG, Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Paediatr Anaesth 2007 17 109 12
10. Tosun Z, Akin A, Guler G, Esmaoglu A, Boyaci A, Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2006 20 515 9
11. Alcorn J, McNamara PJ, Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003 55 667 86
12. Dutton GJ, Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu Rev Pharmacol Toxicol 1978 18 17 35
13. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Mäenpää J, Rane A, Raunio H, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 1994 48 59 64
14. Johnson TN, The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 2003 192 37 48
15. Rane A, Tomson G, Prenatal and neonatal drug metabolism in man. Eur J Clin Pharmacol 1980 18 9 15
16. Su F, Nicolson SC, Gastonguay MR, Barrett JS, Adamson PC, Kang DS, Godinez RI, Zuppa AF, Population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Anesth Analg 2010 110 1383 92
17. Su F, Nicolson SC, Zuppa AF, A dose-response study of dexmedetomidine administered as the primary sedative in infants following open heart surgery. Pediatr Crit Care Med 2013 14 499 507
18. Lee JI, Su F, Shi H, Zuppa AF, Sensitive and specific liquid chromatography-tandem mass spectrometric method for the quantitation of dexmedetomidine in pediatric plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007 852 195 201
19. Díaz SM, Rodarte A, Foley J, Capparelli EV, Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study. Pediatr Crit Care Med 2007 8 419 24
20. Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily M, Lerman J, A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006 105 1098 110
21. Potts AL, Warman GR, Anderson BJ, Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth 2008 18 722 30
22. Harrell FE, Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 New York Springer
23. Ribbing J, Jonsson EN, Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model. J Pharmacokinet Pharmacodyn 2004 31 109 34
24. Anderson BJ, Allegaert K, Holford NH, Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr 2006 165 819 29
25. Holford N, Heo YA, Anderson B, A pharmacokinetic standard for babies and adults. J Pharm Sci 2013 102 2941 52
26. West GB, Brown JH, Enquist BJ, The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999 284 1677 9
27. Anderson BJ, McKee AD, Holford NH, Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet 1997 33 313 27
28. Precedex [Package Insert] 2010 Lake Forest, IL Hospira, Inc.
29. Talke P, Richardson CA, Scheinin M, Fisher DM, Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997 85 1136 42
30. Venn RM, Karol MD, Grounds RM, Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth 2002 88 669 75
31. Chrysostomou C, Schulman SR, Herrera Castellanos M, Cofer BE, Mitra S, da Rocha MG, Wisemandle WA, Gramlich L, A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr 2014 164 276 82.e1
32. Kaivosaari S, Toivonen P, Aitio O, Sipilä J, Koskinen M, Salonen JS, Finel M, Regio-and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos 2008 36 1529 37
33. Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, Manns MP, Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002 50 259 65
34. Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng YF, Guengerich FP, Inui Y, Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 1996 24 515 22
35. Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M, Kumai T, Takashima S, Imaoka S, Funae Y, Yabusaki Y, Kamataki T, Kobayashi S, A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci 1997 61 2567 74
36. Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM, The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 2008 106 79 83
37. Chrysostomou C, Komarlu R, Lichtenstein S, Shiderly D, Arora G, Orr R, Wearden PD, Morell VO, Munoz R, Jooste EH, Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 2010 36 836 42
38. Bokesch PM, Castaneda AR, Ziemer G, Wilson JM, The influence of a right-to-left cardiac shunt on lidocaine pharmacokinetics. Anesthesiology 1987 67 739 44
39. Boer F, Drug handling by the lungs. Br J Anaesth 2003 91 50 60
40. Dutta S, Lal R, Karol MD, Cohen T, Ebert T, Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci 2000 89 519 27